Manuscript Submission: Tips and Challenges


24 September, 1:00 - 2:00 PM (CST)

Register Now

Researchers may be good at drafting their manuscript while strictly adhering to the journal’s guidelines; they may still face challenges in fulfilling the journals’ submission requirements and successfully completing the submission process. In this webinar, we will discuss how authors can avoid making incomplete and incorrect submissions to journals leading to immediate rejection and the importance of publication ethics. We will also discuss ways in which authorship dilemma and pre-submission queries can be addressed. Furthermore, we will cover how plagiarism is detected by journals, how published content can be re-used by researchers, and clarify the copyright-related concerns of authors.

Through this webinar, researchers will learn:

  • Effective tips on preparing a submission-ready manuscript
  • How to avoid ethical dilemmas about authorship decisions?
  • Copyright for journal articles, pre-prints, and conference papers
  • Awareness of ethical guidelines that should be considered before submission
  • Information regarding online submission systems
  • How to write a compelling cover letter for your manuscript?

About Bioscientifica

Bioscientifica Ltd. is a commercial subsidiary of Society for Endocrinology with expertise in publishing, events and association management for more than 20 years. The company aspires to produce high-quality publications to meet the needs of the biomedical community through its publishing portfolio which includes high-impact subscription titles, open access journals, and online resources. Bioscientifica collaborates and strengthens the biomedical and bioscience communities globally for the progress of science and health. All of their profits are redistributed back to Bioscientifica’s partner societies to fund biomedical research.

About the Speaker

Dr. Mingfang Lu General Manager – China, Enago

  • A distinguished publishing expert, ex-Editor-in-Chief, and physicist, Dr. Mingfang has a diverse academic profile and has driven several initiatives in the academic publishing industry in China. He worked with IOP Publishing for >15 years, where he worked in collaboration with organizations such as IOPCAS, NSFC, CAS, CAST, MOST, Peking University, and Tsinghua University.
  • Dr. Mingfang obtained his Ph.D. from Tsinghua University in 1995. For his postdoctoral research, he was associated with the Plasma Materials Surface Sciences at the Institute of Physics of Chinese Academy of Sciences (1995 – 1997); followed by the Plasma Laboratory of Department of Particle Physics, Weizmann Institute of Science in Rehovot, Israel (1999 – 2000); and the Swedish Institute of Space Physics (IRF) in Kiruna from April 2000 to December 2001.
    At IRF, he worked on the Neutral Particle Imager (NPI) for ESA’s ASPERA-3 Mars Express Spacecraft Mission, which continues to work well ever since launch in June 2003 (a similar detector is reported to be on board China’s Chang’e-4 Moon Probe payload soon too).
  • He also worked as guest professor for a short term at Nihon University on neutron emission research and even chaired a Sino–Polish science exchange program on dense plasma focus physics.
  • Dr. Lu has also published >30 research papers in prestigious journals such as Physical Review E, Journal of Physics D, Review of Scientific Instruments, and IEEE Transactions on Plasma Science.
  • At Enago, Dr. Lu is currently leading the team in China. Enago works in collaboration with universities, research institutes, and academic societies in China to help address and overcome the challenges faced by Chinese researchers.

In case of any queries, please feel free to check our webinar FAQs page or email us at academy@enago.com.


Sign-up to read more

Subscribe for free to get unrestricted access to all our resources on research writing and academic publishing including:

  • 2000+ blog articles
  • 50+ Webinars
  • 10+ Expert podcasts
  • 50+ Infographics
  • Q&A Forum
  • 10+ eBooks
  • 10+ Checklists
  • Research Guides